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Recovery from blindness following
accidental quinine overdose
Hildegard Nikki Hall,1,2 Andrew J Tatham1
CASE
A 46-year-old woman presented with
sudden loss of vision in both eyes,
apparent since waking. She also
complained of partial hearing loss. The
previous evening she had experienced
difficulty sleeping due to (long-standing)
restless legs and had self-medicated with
quinine, taking an accidental overdose of
1.8 g.
On admission, she was alert but unable
to perceive light in either eye, and had
fixed, dilated pupils. Other than mild
bilateral sensorineural hearing loss, the
remainder of the neurological examina-
tion was normal. She was
haemodynamically stable, but her ECG
showed QT interval prolongation at 501
ms (normal 350–440); she therefore
received intravenous sodium bicarbonate
for suspected myocardial toxicity.
Ophthalmological review that day
confirmed a visual acuity of no light
perception and a bilateral afferent pupil-
lary defect. Fundal examination suggested
mild retinal oedema. Given the profound
visual loss, we prescribed a 4-week course
of oral nimodipine 60mg 4-hourly, based
on limited evidence from case series.1
PROGRESS
Two days postoverdose, her vision started
to return such that she could perceive
light. Slit lamp fundus examination was
normal at this point. Her sight gradually
improved. By 1month, visual acuity was
6/9 bilaterally, although subjectively her
vision was akin to ‘being under water’.
Colour vision was profoundly reduced:
she could discern the Ishihara control
plate only. Her pupils remained persis-
tently dilated with sluggish direct
reactions to light. Funduscopy now
showed optic disc pallor and retinal
vessel attenuation bilaterally (figure 1),
with thinning of the nasal retinal nerve
fibre layer on optical coherence tomog-
raphy (figure 2). Visual fields were
severely constricted (figure 3A) such that
she remained functionally limited. Elec-
trodiagnostic testing at 3 months was
consistent with quinine overdose, with
reduced electroretinogram amplitude and
abnormal flicker response.
Over 6 months, her visual fields
expanded significantly (figure 3B),
reflecting partial recovery of retinal func-
tion following quinine toxicity.
Figure 1 Fundus photographs showing pale discs and retinal vessel attenuation. The patient’s fundus
appearance was unremarkable in the early stages; the changes seen here were seen from 1month
postoverdose and are secondary to the widespread quinine-induced retinal toxicity. These photographs
were taken at 6 months, at which point there had been some recovery of the visual function but no
further change to the funduscopic appearance.
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DISCUSSION
Acute quinine toxicity produces a well-recognised
constellation of clinical effects, known as cinchonism.
This case demonstrated visual and hearing loss as well as
signs of cardiac instability. In addition, cinchonism may
comprise tinnitus, dizziness, headache, seizures and
vomiting. Quinine is believed to be directly toxic to the
inner retina2 and, while the natural history is of some
recovery over days to weeks, residual visual field
constriction is common and the visionmay remain poor.
There is no high-quality evidence for any treatment
for quinine-related blindness. However, due to the
Figure 2 Optical coherence tomography showing thinning of the retinal nerve fibre layer (RNFL) 1month postquinine overdose.
OU, oculus uterque (both eyes); OD, oculus dexter (right eye); OS, oculus sinister (left eye).
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arteriolar constriction seen in some, there have been
several case reports of treatment to alleviate vaso-
spasm with agents such as nimodipine.1 While the
retinal vasculature was unremarkable at initial assess-
ment, we prescribed nimodipine based on the very
poor level of vision and good safety profile of the
medication.
Due to the narrow therapeutic range of quinine,
visual effects can also rarely occur at normal doses.
Furthermore, as quinine is a commonly prescribed
medication, it is not always readily identified as the
culprit. It should be suspected particularly in the pres-
ence of fixed, dilated pupils and other features of
cinchonism.
Acknowledgements We thank the medical photography staff at the
Princess Alexandra Eye Pavilion for their help.
Contributors HNH and AJT saw the patient and discussed the
content of the manuscript, which was then drafted by HNH and
edited by AJT.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer
reviewed. This paper was reviewed by Neil Anderson, Auckland,
New Zealand.
Open Access This is an Open Access article distributed in
accordance with the terms of the Creative Commons Attribution
(CC BY 4.0) license, which permits others to distribute, remix,
adapt and build upon this work, for commercial use, provided the
original work is properly cited. See: http://creativecommons.org/
licenses/by/4.0/
© Article author(s) (or their employer(s) unless otherwise stated in
the text of the article) 2017. All rights reserved. No commercial use
is permitted unless otherwise expressly granted.
REFERENCES
1 Barrett NA, Solano T. Quinine ocular toxicity: treatment of
blindness using therapy for vasospasm. Anaesth Intensive Care
2002;30:234–5.
2 Christoforidis J, Ricketts R, Loizos T, et al. Optical coherence
tomography findings of quinine poisoning. Clin Ophthalmol
2011;5:75–80.
Figure 3 Humphrey perimetry (SITA-Standard 24–2): (A) 1month postquinine overdose, showing marked constriction of the visual
field; (B) 6 months postquinine overdose, showing clear improvement of the visual field defects.
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